This Mouse Monoclonal antibody specifically detects MS4A1 (Rituximab Biosimilar) in FACS and in vivo. It exhibits reactivity toward Human.
Catalog No. ABIN7795085
Quick Overview for Recombinant MS4A1 (Rituximab Biosimilar) antibody (ABIN7795085)
Target
MS4A1 (Rituximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mouse
Clonality
Monoclonal
Conjugate
This MS4A1 (Rituximab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS), In vivo Studies (in vivo)
Grade
Research Grade
Expression System
Mammalian cells
Purpose
Rituximab Biosimilar, Endotoxin 0.05 EU/mg
Characteristics
B-lymphocyte antigen CD20 encoded by the MS4A1 gene is an activated-glycosylated phosphoprotein on the surface of all B-cells. The function of the membrane protein is to stimulate B-cell immune response, specifically against T-independent antigens though its natural ligand remains unknown. CD20 is important for the development and differentiation of B-cells into plasma cells. CD20 belongs to the membrane-spanning 4A family with common structural features, similar intron/exon splice boundaries, and unique expression patterns among hematopoietic cells and nonlymphoid tissues. Rituximab, a chimeric anti-CD20 monoclonal antibody, destroys B cells and is used to treat diseases with excessive numbers of B cells, overactive B cells, or dysfunctional B cells, such as many lymphomas, leukemias, transplant rejection, and autoimmune disorders.
Purification
Protein A or G affinity column
Purity
>95 % by reducing SDS-PAGE
Endotoxin Level
Less than 0.5 EU/mg of protein as determined by LAL method